Home > Food, Nutrition & Animal Feed > Global Citrus Bioflavonoids Market

Global Citrus Bioflavonoids Market Size, By Source (Orange, Tangarines, Mandarins, Limes & Lemons, Grapefruit), By Product (Hesperitin, Eriocitrin, Apigenin, Diosmin, Naringin, Narirutin), By Type (Conventional, Organic), By Application (Pharmaceuticals & Dietary Supplements, Food & Beverages, Animal Feed, Cosmetics & Personal Care), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026

  • Report ID: GMI4827
  • Published Date: Sep 2020
  • Report Format: PDF

Industry Trends

Citrus bioflavonoids market size may surpass USD 800 Million, in 2019 and is estimated to grow over 7.5% CAGR between 2020 and 2026. Increasing personal health and hygiene awareness along with increasing prevalence of chronic health disorders among population will drive the industry growth.

Citrus bioflavonoids are majorly produced from fruits rich in vitamin C, and act by neutralizing free radicals. These are compounds predominantly found in citrus fruits including grapefruit, tangerines and oranges. These products help in improving blood flow and reduce swelling in human body. Citrus bioflavonoids offer attributes including enhancement of overall immune system and vitamin C absorption which should boost the citrus bioflavonoids market demand.

Get more details on this report - Request Free Sample PDF

The market is segmented based on products including Hesperitin, Eriocitrin, Apigenin, Diosmin, Naringin and Narirutin. Citrus bioflavonoids consists of antioxidants which helps maintaining healthy life. These bioflavonoids are majorly used in supplements manufacturing and are growing in demand across the world, due to rising healthy lifestyle trends.

Growing prevalence of chronic diseases among population including high blood pressure and diabetes due to unhealthy lifestyle practices should accelerate the citrus bioflavonoids market share. These products majorly help in controlling blood sugar levels, blood pressure and inflammation, becoming key aspects augmenting product adoption.

However, companies are investing in new technological developments and production capacity expansions to enhance their product portfolio. For instance, In March 2019, Yakult Honsha Co. launched its novel synbiotic beverage in South Korea; this product is incorporated with active bioflavonoid named MicrobiomeX.

Coronavirus pandemic has increased Citrus bioflavonoids demand owing to rich vitamin C content which majorly boost immunoregulation and improve digestive health of patient. However, the pandemic has led to implementation of travel ban and closedown of production plants, offices & marketplaces by governments all over the globe. These measures have led to value chain disruptions throughout the globe which have adversely affected raw materials supply for production of Citrus bioflavonoids. This pandemic has led to the shutdown of manufacturing plants globally which may decrease Citrus bioflavonoids utilization.

Persuading health benefits offered by Eriocitrin will boost market growth


Get more details on this report - Request Free Sample PDF

Eriocitrin segment is estimated to witness significant gains over 9% by the end of 2026. Eriocitrin is predominantly used in dietary supplements manufacturing wing to its lipid lowering attributes in liver cell. Also, Eriocitrin can be used to regulate blood glucose levels which should accelerate the citrus bioflavonoids market.

This product is a flavone glycoside majorly found in lemon. This product is predominantly consumed before acute exercise which helps to maintain liver glutathione redox status. Owing to the product’s attributes, it has depicting a considerably high demand, enabling manufacturing companies to launch newer products.

For instance, In July 2019, Ingredients by Nature (IBN) launched its new product named Eriomin which has efficacy in prediabetes management. This product has high potency in mixture of Eriocitrin & other flavonoids supporting glycemic control.

Increasing application scope in food & beverages industry  will stimulate Citrus bioflavonoids market growth


Get more details on this report - Request Free Sample PDF

Food & beverages application is anticipated to reach over USD 250 million by 2026. The food & beverages application segment is anticipated to hold a significant share in the overall Citrus bioflavonoids market. Rising product usage in food application owing to strong demand from beverages companies coupled with increasing need for clean label products by consumers will push the application segment outlook over the forecast period.

Rising trends of eliminating utilization of titanium dioxide, mono- & di-glycerides, phosphates and carrageenan by food manufacturers should open up product opportunities. These products are substituting clouding agents including gum Arabica in protein shakes, juices & coffee drinks and carrageenan in plant-based beverages which should boost Citrus bioflavonoids market growth.

Rising European pharmaceutical industry will stimulate product demand

Get more details on this report - Request Free Sample PDF


Europe is estimated to witness significant gains over 7% through 2026. Strong growth in the pharmaceutical sector will create potential growth opportunities for Citrus bioflavonoids industry players in the region. Moreover, increasing diabetic patients in the region should result in augmenting regional Citrus bioflavonoids market growth. For instance, in 2019, according to the International Diabetes Federation reports, prevalence of diabetes in European is estimated to increase from 6.3% in 2019 to around 7.8% by 2045.

Supportive initiatives introduced by EU commission for supporting pharmaceutical companies to produce innovative products and to address unmet medical conditions for fostering overall regional health status of the population should accelerate the citrus bioflavonoids market trends. For instance, PriMe initiative or Priority Medicines initiatives launched by the EU Commission in which private pharmaceutical manufacturers and government work together to research and development new medicines for unmet medical conditions.

New product releases and R & D to be key business strategies by manufacturers

Global citrus bioflavonoids industry is competitive with major players including Organika Health Products Inc., Nature LLC, Solgar Inc., Freeda Vitamins Inc., NOW Foods, Natural Factors Inc., Country Life, Cayman Chemical Company, Merck KGaA , Nans Products, Nacalai Tesque Inc., BOC Sciences, Santa Cruz Biotechnology, Inc., Hunan Sunfull Bio-tech Co., Ltd., J&K Scientific Ltd., Hunan Yuantong Pharmaceutical Co., Ltd., Yaan Times Biotech, Destilaciones Bordas Chinchurreta S.A., Yakult Honsha Co., Ltd and MORRE-TEC Industries.

Participants in the citrus bioflavonoids market are incorporating strategies including capacity expansions, mergers & acquisitions, new product launches and partnerships & collaborations. For instance, In 2017, Ingredients by Nature LLC launched its new product line under the Brewster brand for Citrus bioflavonoids. The company announced that Brewster brand offering Citrus bioflavonoids will be available in powder form and granules which offers wide range of bioflavonoid profiles. Thus, this product launch will enhance its product portfolio and attain profitability.

Citrus bioflavonoids market report includes in-depth coverage of the industry trends, with estimates & forecast in terms of volume (Tons) and revenue (USD Million) from 2015 to 2026, for the following segments:

By Source

  • Orange, tangarines, mandarins
  • Limes & lemons
  • Grapefruit
  • Others

By Product

  •  Hesperitin
  • Eriocitrin
  • Apigenin
  • Diosmin
  • Naringin
  • Narirutin
  • Others

By Type

  • Conventional
  • Organic

By Application

  • Pharmaceuticals & dietary supplements
  • Food & beverages
  • Animal feed
  • Cosmetics & Personal care

The above information has been provided for the following regions:

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Poland
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Thailand
    • Brazil
  • MEA
    • South Africa
    • UAE
    • Saudi Arabia


Authors: Kunal Ahuja, Tushar Malkani

Frequently Asked Questions (FAQ) :

In 2019, the Citrus bioflavonoids market size was over USD 800 Million and is projected to grow at a CAGR of over 7.5% through 2026.
Due to the worldwide travel ban and nationwide lockdowns, raw material supply and manufacturing plants are adversely affected which in turn has reduced Citrus bioflavonoid utilization.
Eriocitrin, which is mainly used in dietary supplements manufacturing wing to its lipid reducing attributes in the liver cell, is projected to witness noteworthy gains of over 9% through 2026.
The Europe Citrus bioflavonoids market is expected to witness significant gains of more than 7% through 2026. Robust growth in the pharmaceutical sector will create a scope for potential growth opportunities for Citrus bioflavonoids.

Buy Now

Premium Report Details

  • Base Year: 2019
  • Companies covered: 20
  • Tables & Figures: 316
  • Countries covered: 20
  • Pages: 230
  • Upcoming Report: Details can be customized to meet your information and data needs. Feel free to share your detailed research requirements via this form.

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount